Veradermics, Incorporated (MANE)

Veradermics, Incorporated (MANE) is a Biotechnology company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $5.8B; returns 1 day +0.2%, 1 week +27.5%.

Veradermics, Incorporated (NYSE: MANE) is a late-stage clinical biopharmaceutical company specializing in the development and commercialization of therapeutics for prevalent aesthetic and dermatological conditions. The company is currently pre-revenue, with its valuation driven by its lead product candidate, VDPHL01—a proprietary oral, extended-release (ER) formulation of minoxidil.

Groups MANE belongs to

• Recent IPOs
• Dermatology
• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biopharma
• Healthcare Innovation
• 505(b)(2) Pathway
• Healthcare
• Alopecia Areata

MANE financial model: income statement, cash flow and balance sheet